Andriy Nykyforuk

Dr. Andriy Nykyforuk

Uzhhorod National University, Uzhhorod, Zakarpats’ka Oblast’, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Viruses
Verified
Journal Article
Open access
PDF file
Pavlo PetakhPavlo Petakh
Pavlo Petakh
IKIryna Kamyshna
Iryna Kamyshna
Andriy NykyforukAndriy Nykyforuk
Andriy Nykyforuk
RYRouan Yao
Rouan Yao
JIJohn F. Imbery
John F. Imbery
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
Coronavirus disease 2019, or COVID-19, is a major challenge facing scientists worldwide. Alongside the lungs, the system of organs comprising the GI tract is commonly targeted by COVID-19. The dysbiotic modulations in the intestine influence the disease severity, potentially due to the ability of the intestinal microbiota to modulate T lymphocyte functions, i.e., to suppress or activate T cell subpopulations. The interplay between the lungs and intestinal microbiota is named the gut–lung axis. One of the most usual comorbidities in COVID-19 patients is type 2 diabetes, which induces changes in intestinal microbiota, resulting in a pro-inflammatory immune response, and consequently, a more severe course of COVID-19. However, changes in the microbiota in this comorbid pathology remain unclear. Metformin is used as a medication to treat type 2 diabetes. The use of the type 2 diabetes drug metformin is a promising treatment for this comorbidity because, in addition to its hypoglycemic action, it can increase amount of intestinal bacteria that induce regulatory T cell response. This dual activity of metformin can reduce lung damage and improve the course of the COVID-19 disease.

6 December 2022 in Vector-Borne and Zoonotic Diseases
Verified
Journal Article
Closed access
Pavlo PetakhPavlo Petakh
Pavlo Petakh
VIVitaliia Isevych
Vitaliia Isevych
IMIssah Bin Mohammed
Issah Bin Mohammed
Andriy NykyforukAndriy Nykyforuk
Andriy Nykyforuk
LRLarysa Rostoka
Larysa Rostoka
Background: Leptospirosis is a bacterial zoonosis of worldwide distribution with a wide spectrum of clinical presentations that range from subclinical or mild to severe and fatal outcomes. Identifying clinical predictors for the severe form of the disease is critical to reduce disease complications and death. As a result, we conducted a retrospective case–control study to identify clinical markers of mortality in leptospirosis patients from the Transcarpathian region. Materials and Methods: The study used 102 medical records of patients with leptospirosis in the period from 2009 to 2019. There were 26 fatal cases and 76 survivors. Predictors were examined using univariate and bivariate statistics. Results: Fatal and nonfatal groups did not differ in age or gender composition ( p > 0.5), nor did they differ in signs or symptoms, except that oliguria occurred significantly more often in fatal cases ( p < 0.001). Laboratory diagnostic tests, however, differed between outcomes in 7/9 recorded variables; primarily associated with liver and kidney function as well thrombocytopenia and elevated white blood cell counts for fatal cases ( p < 0.01 for all variables). Conclusions: Logistic regression analysis indicated that a combination of creatinine levels and direct bilirubin levels were the best predictors of patient outcome. The specificity of the model was 90.9% and the area under the receiver operator characteristic function as 93.6%. This model can be used when a patient is admitted to a hospital to better characterize patient risk.


26 October 2020 in Pharmacia
Verified
Journal Article
Open access
PDF file
Andriy NykyforukAndriy Nykyforuk
Andriy Nykyforuk
LFLiudmyla Fira
Liudmyla Fira
PLPetro Lykhatskyi
Petro Lykhatskyi
VPVictor Pyda
Victor Pyda
Disorders of protein metabolism – one of the pathologies, the treatment of which is an urgent problem of modern medicine and pharmacy. The importance of the problem is stipulated due to the prevalence of diseases that are accompanied by a violation of protein metabolism in the body. Restoration of protein resources during such conditions requires adequate intake of structural components from the outside – proteins, amino acids and other biologically active substances-correctors of protein metabolism. In recent decades, much attention has been paid to the discoveries of anabolic agents of natural origin, especially from plants. We conducted research on the study of the anabolic and antioxidant properties of dry extract of spinach garden leaves on the model of food deprivation in rats. Established, that the dry extract at the dose of 100 mg/kg body weight of animals prevents the development of organic disorders of protein metabolism, oxidative stress, prevents a sharp decrease in body weight and slows down the generalized catabolism caused by starvation in rats. Under the influence of the extract on the model of food deprivation, the diuretic function of the kidneys is preserved at the physiological level.